查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832285

生物保存市场按产品类型、技术、样品类型、应用和最终用户划分－2025-2032 年全球预测

Biopreservation Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年生物防腐市场将成长 261.1 亿美元，复合年增长率为 27.92%。

主要市场统计数据
基准年2024年 36.4亿美元
预计2025年 46.7亿美元
预测年份：2032年 261.1亿美元
复合年增长率（%） 27.92%

生物保存已从实验室的便利手段发展成为支持现代医疗服务、先进医疗手段和生命科学研究的关键任务能力。细胞和基因治疗的进步、器官和组织库计画的不断扩展以及复杂生技药品的全球部署，共同推动了对生物材料可靠长期保存的商业需求。同时，低温技术、保存化学和数位监控技术的进步使得可靠的保存在技术上可行，但也带来了采购、法规遵循和人员能力方面的挑战。

事实上，组织面临着多方面的挑战，包括将各种储存技术整合到端到端工作流程中、管理专用耗材和设备的库存，以及透过日益国际化的供应路线来维护低温运输的完整性。这些压力与改善病患治疗效果、减少浪费和扩展临床服务的机会并存。因此，领导者必须在短期营运选择与实现可扩展储存能力的策略性投资之间取得平衡，同时确保其管治框架符合不断变化的监管和认证要求。

本引言提供了高阶主管层面的总结，探讨了技术拐点、政策驱动因素、商业性压力以及机构可以采取的强化其保存策略的实际步骤。本文强调，临床团队、供应链经理和研发团队之间需要跨职能协作，将保存科学转化为可靠且可重复的实践。最终，协作方式将决定哪些机构能够持续支持下一代疗法、扩大捐赠项目，并降低与供应中断和合规性差距相关的风险。

生物保存技术、监管期望和商业化路径的变革将重新定义生物样本的储存和使用方式。

在技​​术进步、监管趋严和商业化模式不断发展的推动下，生物保存领域正在经历一场变革。玻璃化冷冻和先进的冷冻干燥技术等新型保存方法正在挑战传统的低温运输模式，而即时监控和物联网支援的保存系统则提升了人们对资料连续性和可追溯性的期望。这些技术创新并非凭空而来；它们正在重塑企业设计储存设施、培养人才以及协商供应商关係的方式。

同时，世界各地的监管机构正在加强对生物製药处理、储存检验和保管链文件的审查。这促使人们从临时的实验室级实践转向正式的品管体系，其中包括校准方案、通讯协定监测和记录在案的紧急时应对计画。随着细胞和基因疗法从临床试验阶段转向更广泛的商业化，对可扩展、检验的储存解决方案的需求正在加速成长。为此，耗材和仪器製造商正在提供模组化、可互通的产品，以减少整合摩擦并缩短检验时间。

这种转变既带来了复杂性，也带来了机会。积极采用互操作系统、实施强大的数位可追溯性、并使采购符合监管要求的机构将降低营运风险并加快治疗速度。相反，行动迟缓的机构则面临腐败加剧、审核缺陷增加以及新治疗方法取得管道受限的风险。简而言之，医疗格局正在从单点产品转向需要跨职能协调和策略性投资的系统导向解决方案。

2025年美国关税对生物保存供应链、试剂采购、设备采购及跨境临床物流的累积影响

2025年实施的关税变化为全球生物保存供应链带来了新的复杂性，影响了关键试剂、特殊耗材和高价值设备的采购经济效益。随着各机构重新评估其供应商组合、规划库存缓衝，并评估进口和本地采购方案的总合到岸成本，其累积影响在整个采购週期中显而易见。对一些机构而言，关税环境加速了关于如何配置生产基地、建立区域配送中心以及优先实施多采购策略以增强韧性的讨论。

在营运方面，设备和消耗品进口关税的上涨延长了采购前置作业时间，并增加了设备升级的资本支出。采购和财务主管的应对措施包括与供应商重新谈判合同，寻求包含价格保护条款的长期采购协议，并评估租赁和服务模式以减轻前期投资负担。对于供应商而言，关税正在推动其做出策略决策，例如本地组装、扩大经销商网路以及将投资重点放在需求充足且稳定的市场。

在临床方面，关税可能会透过改变先进疗法和专业储存工作流程的经济效益，间接影响药品的可近性，促使医疗保健系统优先考虑那些储存成本能够透过临床价值得到合理证明的干预措施。从风险角度来看，医疗保健机构现在需要在其应急计划中考虑关税波动，对其供应商生态系统进行压力测试，并保持文件透明，以支持海关和监管机构的询问。在这种环境下，策略性采购、严格的供应商资格审查和灵活的物流规划是业务永续营运的关键要素。

将产品类型、储存技术、样本类别、应用程式和最终用户动态与策略采用模式连结起来的关键细分洞察

要了解生物保存领域，需要综合考虑产品类型、保存技术、样本类别、临床和研究应用以及最终用户行为。从产品角度来看，生物保存领域分为耗材与设备两大类。耗材包括冷冻保护剂、培养基、管瓶及冷冻试管。在冷冻保护剂中，二甲基亚砜(DMSO) 和甘油在细胞和组织实验中仍然占主导地位，每种保护剂的选择取决于其相容性和下游应用需求。设备组合涵盖超低温冷冻柜、监控系统和储存系统，其选择取决于通量需求、预期验证以及与设施环境控制的整合。

技术的选择决定了操作设计。低温保存、低温储存、冷冻干燥和玻璃化冷冻在复杂性、稳定性和对不同生物样本的适用性方面各有优劣。虽然低温保存和低温储存通常用于细胞和血液成分，但冷冻干燥和玻璃化冷冻越来越多地被考虑用于特殊组织产品和某些生物体液，因为这些产品的常温稳定性和减少对低温运输的依赖性是其优势。每种技术的选择都会对后续的培训、验证和品质监控产生影响。

样本类型的考虑可以进一步优化采购和营运优先顺序。生物体液、血液成分、细胞、器官和组织在处理、控制和效价保存方面都有独特的要求，这些要求会影响耗材的选择和设备的尺寸。从辅助生殖和血库到细胞疗法、器官保存和组织工程等各种应用，都对产品和技术提出了特定的性能要求。最后，最终用户（包括血库、生育诊所、医院和诊所、製药和生物技术公司以及研究机构）的规模、监管严格程度和预算限制各不相同，这反过来又决定了他们的采用路径和供应商选择标准。整合这些细分视角，决策者能够将技术投资与实际工作流程、监管要求和策略重点结合。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和策略考量推动招聘、投资和政策协调

美洲、欧洲、中东和非洲以及亚太地区的区域动态显着影响着生物保存的优先事项、投资模式和监管互动。在美洲，成熟的临床基础设施、不断扩展的细胞和基因治疗产品线以及整合的商业管道推动了对高通量低温设备和经过验证的耗材的需求，而法律规范则强调可追溯性和品质系统。这创造了一个环境，​​使得能够提供快速验证支援的规模化解决方案和服务模式对机构投资者尤其具有吸引力。

在欧洲、中东和非洲，严格的监管要求与多样化的医疗保健服务模式相互作用，导致医疗服务采用格局差异化。严格监管的地区优先考虑经过认证的系统、详尽的文件记录以及与现有品管系统的互通性，而基础设施受限的市场则可能更倾向于降低低温运输复杂性的解决方案，例如冷冻干燥技术和简化的储存工作流程。为此，供应商通常会寻求针对特定地区的验证方案，并与当地经销商合作，以应对多样化的采购和合规环境。

亚太地区的需求正在快速成长，这得益于生物技术研发投资的增加、生产能力的提升以及政府对先进疗法的支持。该地区的多样性意味着一些市场正在迅速采用尖端储存技术，而其他市场则优先考虑本地生产和高性价比的耗材。在整个地区，跨境监管协调努力和供应链本地化的趋势正在塑造供应商策略，鼓励建立伙伴关係伙伴关係、区域仓储和客製化服务，以满足司法管辖区的要求并缩短前置作业时间。

策略公司层面的洞察，重点在于竞争格局、伙伴关係、产品系列、製造地和创新管道

生物保存公司越来越多地将产品创新、垂直整合和服务产品相结合，以在充满技术挑战的环境中脱颖而出。领先的公司正在寻求端到端解决方案，将耗材、检验的仪器和数据丰富的监测平台相结合，以减轻临床和研究客户的整合负担。耗材製造商和仪器供应商之间的策略伙伴关係日益普遍，从而实现了简化验证和采购的捆绑解决方案。

製造商正在投资模组化设计和互通性标准，以简化与设施管理系统的集成，并支援远端监控和预测性维护。同时，契约製造製造商和专业物流供应商正在扩展其能力，以提供区域组装、最后低温运输冷链服务和受监管的仓储中心。这些措施旨在缩短前置作业时间，并降低买家在管理跨地域的多家供应商时面临的营运复杂性。

此外，各公司正透过将验证支援、文件包和培训服务纳入其商业流程，使其产品蓝图与监管趋势保持一致。这种方法使客户能够在履行合规义务的同时加快采用。他们的智慧财产权策略、旨在填补产品组合缺口的定向併购以及对生产冗余的投资，也反映出他们对供应连续性和可靠地服务临床和研究领域的能力的重视。

为产业领导者提供切实可行的建议，以加速復原能力、降低供应链风险并在治疗、临床和研究领域中获得价值

产业领导者应采取一系列综合行动，增强韧性，释放价值，并支援维护解决方案的可扩展部署。首先，协调采购和临床相关人员，制定统一的规范，优先考虑互通性、资料完整性和检验的便利性。这将减少产品认证过程中的摩擦，并缩短部署时间。其次，实现供应商网路多元化，纳入能够提供本地组装、验证支援和快速物流的区域合作伙伴和服务供应商，减少跨境关税波动和运输中断带来的风险。

第三，投资数位监控和预测性维护，以提高运转率并实现主动品管。这些投资支持监管文件，并降低可能危及生物材料的温度超调的可能性。第四，如果担心资金限製或关税导致的成本上升，请考虑租赁安排、託管服务或耗材捆绑，并建立商业合约以平衡资本和营运支出。第五，将培训和变更管理纳入部署，以确保员工能力与技术的复杂性和检验义务相符。

最后，纳入基于情境的应急计划，明确模拟关税、供应商故障模式、紧急运输路线等因素的影响。当供应链压力因素出现时，这就能够更快、更基于证据地做出决策。全面检视这些行动，有助于组织从被动管理转向对维护能力进行策略性管理。

透明的调查方法，概述资料来源、检验通讯协定、专家参与和分析框架，以确保情报的可靠性

本研究综合基于多资讯来源方法，强调主要专家的参与、查阅技术文献和检验供应商文件。主要输入包括与临床和供应链负责人进行结构化访谈、与设备和耗材製造商进行技术简报，以及与法规事务专家进行磋商，以确保对合规性要求进行切实可行的解读。这些定性见解与技术标准、产品规格和已发布的方法验证指南相互参照，以验证操作和性能声明的准确性。

分析通讯协定强调可追溯性和可重复性。产品功能和操作方法的声明均已根据製造商技术说明书、同行评审方案（如有）和记录范例检验。专家评审员提供了关于采用障碍、培训需求和检验时间表的背景信息，为建议和风险评估提供了依据。我们实施了资料清理，以确保输入资料是最新的，如果未经独立检验，则专有资料或供应商提供的效能资料将被标记并视为有条件资料。

完整的交付成果明确阐述了研究的局限性和注意事项，包括尚未出现实证证据的领域以及不同地区监管解释存在差异的领域。调查方法在技术深度和实际操作适用性之间取得平衡，使决策者能够应用研究见解，同时也认识到需要进一步进行局部检验和前导测试的领域。

结论概述了临床、商业和研究生态系统相关人员的策略要点、新兴风险和近期优先事项

总而言之，生物保存领域处于科学创新、操作严谨性和供应链复杂性的交会点。保存化学和技术的进步为扩大临床计画和实现先进疗法创造了新的机会，而监管和商业性压力正在重塑采购和检验的优先事项。这些因素的综合作用促使人们转向强调互通性、资料连续性和弹性采购的整合解决方案。

积极调整筹资策略、投资数位监控并协调跨职能相关人员的组织最有可能实现现代保存技术的临床和营运效益。相反，延迟策略升级的公司则面临浪费增加、临床能力受限以及难以满足监管要求的风险。因此，当务之急应着重于供应商多元化、有针对性地配置资本以实现互通性，以及将培训和检验实践制度化。

总体而言，务实、系统导向的方法，在技术应用与严格的品质管治之间取得平衡，将使医疗保健提供者、研究机构和商业开发商能够将保护科学转化为可靠的营运能力。相关人员应将本文提供的见解作为有针对性的测试、采购决策和政策参与的基础。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 引入自动化低温保存系统，提高细胞治疗製造的可重复性和产量
  • 开发新型冰重结晶抑制剂以提高长期储存期间生技药品的活力
  • 在辅助生殖技术中采用玻璃化冷冻通讯协定来提高胚胎和卵子的存活率
  • 整合永续的冷冻保存技术，以降低生物银行的成本和环境影响
  • 温度敏感疫苗冷冻干燥技术的进步延长了保质期，无需依赖低温运输
  • 监管协调努力，以标准化全球生物保存工作流程和材料品管标准

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 生物保存市场（依产品类型）

  • 耗材
    • 冷冻保护剂
      • DMSO
      • 甘油
    • 媒体
    • 管瓶和试管
  • 装置
    • 低温冷冻库
    • 监控系统
    • 储存系统

第九章 生物保存市场（按技术）

  • 冷冻保存
  • 冷藏
  • 冷冻干燥
  • 玻璃化冷冻

第 10 章。按样品类型分類的生物保存市场

  • 体液
  • 血液成分
  • 细胞
  • 器官
  • 组织

第十一章按应用分類的生物保存市场

  • 辅助生殖技术
  • 血液保存
  • 细胞疗法
  • 器官保存
  • 组织工程

第 12 章 生物保存市场（依最终使用者）

  • 血库
  • 不孕不育诊所
  • 医院和诊所
  • 製药和生物技术公司
  • 研究机构

第 13 章按地区分類的生物保存市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章生物保存市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。各国生物保存市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • BioLife Solutions, Inc.
    • Azenta, Inc.
    • Cryoport, Inc.
    • Avantor, Inc.
    • Brooks Automation, Inc.
    • Lonza Group AG
    • Sartorius AG
Product Code: MRR-437D45957B50

The Biopreservation Market is projected to grow by USD 26.11 billion at a CAGR of 27.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.64 billion
Estimated Year [2025] USD 4.67 billion
Forecast Year [2032] USD 26.11 billion
CAGR (%) 27.92%

Biopreservation has evolved from a laboratory convenience to a mission-critical capability underpinning modern healthcare delivery, advanced therapeutics, and life sciences research. Advances in cell and gene therapies, expanded organ and tissue banking initiatives, and the global roll-out of complex biologics have together increased the operational imperative to preserve biological materials reliably over extended periods. Concurrently, improvements in cryogenic engineering, preservation chemistries, and digital monitoring have made high-integrity storage more technically achievable, yet have also raised the bar for procurement, regulatory compliance, and workforce competency.

In practice, organizations face a multifaceted set of challenges: integrating diverse preservation technologies into end-to-end workflows, managing specialized consumable and equipment inventories, and maintaining cold chain integrity across increasingly international supply routes. These pressures coexist with opportunities to enhance therapeutic outcomes, reduce waste, and extend the reach of clinical services. As a result, leaders must balance near-term operational choices with strategic investments that enable scalable preservation capabilities, while ensuring governance frameworks meet evolving regulatory and accreditation expectations.

This introduction sets the stage for an executive-level synthesis that examines technological inflection points, policy drivers, commercial pressures, and practical steps organizations can apply to fortify their preservation strategies. It underscores the need for cross-functional alignment among clinical teams, supply chain managers, and R&D groups to translate preservation science into reliable, reproducible practice. Ultimately, a coordinated approach will determine which institutions can sustainably support next-generation therapies, expand donor programs, and mitigate risks tied to supply disruptions and compliance gaps.

Transformative shifts in biopreservation technology, regulatory expectations, and commercialization pathways redefining how biological materials are preserved and mobilized

The landscape of biopreservation is undergoing transformative shifts driven by converging technological advances, regulatory intensification, and evolving commercialization models. Emerging preservation methods such as vitrification and refined lyophilization techniques are challenging legacy cold chain paradigms, while real-time monitoring and IoT-enabled storage systems are elevating expectations for data continuity and traceability. These innovations are not isolated; they are reshaping how organizations design storage facilities, train personnel, and negotiate supplier relationships.

At the same time, regulatory bodies worldwide are tightening oversight of biologic handling, storage validation, and chain-of-custody documentation. This has prompted a move from ad hoc, lab-level practices to formalized quality management systems encompassing calibration protocols, environmental monitoring, and documented contingency plans. Commercial pressures are also reshaping the market: as cell and gene therapies move from clinical trials into broader commercialization, the need for scalable, validated preservation solutions has accelerated. Manufacturers of consumables and equipment are responding with modular, interoperable offerings designed to reduce integration friction and shorten validation timelines.

These shifts create both complexity and opportunity. Organizations that proactively adopt interoperable systems, implement robust digital traceability, and align procurement with regulatory expectations can reduce operational risk and speed time-to-treatment. Conversely, institutions that lag in adoption risk increased spoilage, audit findings, and constrained access to emerging therapies. In short, the landscape is moving from discrete products toward systems-oriented solutions that require cross-functional coordination and strategic investment.

Cumulative impact of United States tariffs in 2025 on biopreservation supply chains, reagent sourcing, equipment procurement, and cross-border clinical logistics

Tariff changes implemented in 2025 introduced a new layer of complexity to global biopreservation supply chains, affecting the sourcing economics for critical reagents, specialized consumables, and high-value equipment. The cumulative effects are noticeable across procurement cycles as organizations reassess supplier portfolios, plan inventory buffers, and evaluate the total landed cost of imports versus regional sourcing options. For some institutions, the tariff environment has accelerated conversations about reshoring production, establishing regional distribution hubs, and prioritizing multi-sourcing strategies to strengthen resilience.

Operationally, increased import duties on equipment and consumables have translated into longer procurement lead times and higher capital outlays for facility upgrades. Procurement and finance leaders have responded by renegotiating supplier contracts, seeking longer-term purchase agreements that include price protection clauses, and evaluating leasing or service-based models to mitigate upfront capital burdens. For suppliers, tariffs have encouraged strategic decisions including local assembly, expanded distributor networks, and targeted investments in markets where demand is both material and stable.

Clinically, tariffs can indirectly affect access by shifting the economics of advanced therapies and specialized preservation workflows, prompting healthcare systems to prioritize interventions where preservation costs can be justified by clinical value. From a risk perspective, organizations must now account for tariff volatility in contingency planning, stress-test their supplier ecosystems, and maintain transparent documentation to support customs and regulatory inquiries. In this environment, strategic procurement, rigorous supplier qualification, and flexible logistics planning become essential components of operational continuity.

Key segmentation insights linking product types, preservation technologies, sample classes, applications, and end-user dynamics to strategic adoption patterns

Understanding the biopreservation landscape requires an integrated view of product typologies, preservation technologies, the array of sample classes, clinical and research applications, and end-user behaviors. From a product perspective, offerings split into consumables and equipment, with consumables encompassing cryoprotectants, media, and vials and tubes. Within cryoprotectants, dimethyl sulfoxide (DMSO) and glycerol remain dominant chemistries for cell and tissue work, each selected based on compatibility profiles and downstream application requirements. Equipment portfolios cover cryogenic freezers, monitoring systems, and storage systems, and their selection depends on throughput needs, validation expectations, and integration with facility environmental controls.

Technology choices shape operational design. Cryopreservation, hypothermic storage, lyophilization, and vitrification offer distinct trade-offs in complexity, stability, and suitability for different biological materials. Cryopreservation and hypothermic storage are commonly used for cells and blood components, while lyophilization and vitrification are increasingly considered for specialized tissue products and certain biological fluids where ambient stability or reduced cold chain dependence is advantageous. Each technology choice has downstream implications for training, validation, and quality oversight.

Sample type considerations further refine procurement and operational priorities. Biological fluids, blood components, cells, organs, and tissues present unique handling, containment, and potency-preservation requirements that inform both consumable selection and equipment sizing. Applications-ranging from assisted reproductive technology and blood preservation to cell therapy, organ preservation, and tissue engineering-drive specific performance attributes for products and technologies. Finally, end users such as blood banks, fertility clinics, hospitals and clinics, pharmaceutical and biotech companies, and research institutes differ in scale, regulatory rigor, and budgetary constraints, which in turn shape adoption pathways and supplier selection criteria. Integrating these segmentation lenses enables decision-makers to align technology investments with practical workflows, regulatory obligations, and strategic priorities.

Regional dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive adoption, investment, and policy alignment

Regional dynamics significantly influence biopreservation priorities, investment patterns, and regulatory interactions across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, established clinical infrastructure, expanding cell and gene therapy pipelines, and integrated commercial channels drive demand for high-throughput cryogenic equipment and validated consumables, while regulatory frameworks emphasize traceability and quality systems. This creates an environment where scaled solutions and service models that offer rapid validation support are particularly attractive to institutional buyers.

Across Europe, Middle East & Africa, the interplay between stringent regulatory expectations and diverse healthcare delivery models results in a heterogeneous adoption landscape. High-regulation jurisdictions prioritize certified systems, thorough documentation, and interoperability with existing quality management systems, whereas markets with constrained infrastructure may favor solutions that reduce cold chain complexity, such as lyophilization or simplified storage workflows. In response, suppliers often pursue region-specific validation packages and collaborate with local distributors to navigate varied procurement and compliance environments.

Asia-Pacific presents a fast-growing demand profile driven by rising investments in biotech R&D, expanding manufacturing capabilities, and government support for advanced therapies. The diversity of the region means that some markets rapidly adopt cutting-edge preservation technologies, while others place emphasis on localized manufacturing and cost-effective consumables. Across all regions, cross-border regulatory harmonization efforts and supply chain localization trends shape supplier strategies, prompting partnerships, regional warehousing, and tailored service offerings to meet jurisdictional requirements and reduce lead times.

Competitive landscape and strategic company-level insights focusing on partnerships, product portfolios, manufacturing footprints, and innovation pipelines

Company strategies in the biopreservation space increasingly combine product innovation, vertical integration, and service-enabled offerings to differentiate in a technically demanding environment. Leading organizations pursue end-to-end solutions that integrate consumables, validated equipment, and data-rich monitoring platforms, thereby reducing the integration burden for clinical and research customers. Strategic partnerships between consumable manufacturers and equipment providers are becoming more common, enabling bundled solutions that simplify validation and procurement.

Manufacturers are investing in modular designs and interoperability standards to ease integration with facility management systems and to support remote monitoring and predictive maintenance. In parallel, contract manufacturers and specialized logistics providers are expanding capabilities to offer regional assembly, cold-chain last-mile services, and regulated storage hubs. These moves aim to shorten lead times and reduce the operational complexity that buyers face when managing multiple vendors across disparate geographies.

Additionally, companies are aligning product roadmaps with regulatory trends by embedding validation support, documentation packages, and training services into their commercial offerings. This approach helps customers accelerate implementation while meeting compliance obligations. Intellectual property strategies, targeted M&A to fill portfolio gaps, and investments in manufacturing redundancy are also evident, reflecting a prioritization of supply continuity and the ability to serve both clinical and research segments reliably.

Actionable recommendations for industry leaders to accelerate resilience, de-risk supply chains, and capture value across therapeutic, clinical, and research segments

Industry leaders should adopt an integrated set of actions that strengthen resilience, unlock value, and support scalable deployment of preservation solutions. First, align procurement and clinical stakeholders to create unified specifications that prioritize interoperability, data integrity, and ease of validation. Doing so reduces friction during product qualification and shortens implementation timelines. Second, diversify supplier networks to include regional partners and service providers capable of local assembly, validation support, and responsive logistics, thereby reducing exposure to cross-border tariff volatility and shipping disruptions.

Third, invest in digital monitoring and predictive maintenance to improve uptime and enable proactive quality management. These investments support regulatory documentation and reduce the likelihood of temperature excursions that can compromise biological materials. Fourth, structure commercial agreements to balance capital and operational expenditures; explore leasing, managed services, or bundled consumable agreements when capital constraints or tariff-driven cost increases are a concern. Fifth, embed training and change management into rollouts to ensure that staff competencies keep pace with technological complexity and validation obligations.

Finally, incorporate scenario-based contingency planning that explicitly models tariff impacts, supplier failure modes, and emergency transport routes. This will enable faster, evidence-based decisions when supply chain stressors materialize. Collectively, these actions will help organizations transition from reactive management to strategic stewardship of their preservation capabilities.

Transparent research methodology outlining data sources, validation protocols, expert engagements, and analytical frameworks used to ensure robust intelligence

This research synthesis is built on a multi-source methodology that emphasizes primary expert engagement, curated technical literature, and validated supplier documentation. Primary inputs included structured interviews with clinical and supply chain leaders, technical briefings with equipment and consumable manufacturers, and consultations with regulatory affairs specialists to ensure practical interpretation of compliance requirements. These qualitative insights were cross-referenced with technical standards, product specifications, and published method validation guidance to triangulate operational and performance claims.

Analytical protocols emphasized traceability and reproducibility. Claims about product capabilities and operational practices were validated against manufacturer technical sheets, peer-reviewed protocols where available, and documented real-world case examples. Expert reviewers provided context on adoption barriers, training needs, and validation timelines, which informed the recommendations and risk assessments. Data hygiene practices were applied to ensure that inputs were current, and any proprietary or vendor-supplied performance data were labeled and treated as conditional when not independently verified.

Limitations and caveats are clearly stated within the full deliverable, including areas where empirical evidence remains emergent or where regional regulatory interpretations diverge. The methodology balances depth of technical understanding with practical operational applicability, enabling decision-makers to apply the insights while acknowledging areas that warrant further localized validation or pilot testing.

Conclusion synthesizing strategic takeaways, emergent risks, and near-term priorities for stakeholders across clinical, commercial, and research ecosystems

In conclusion, the biopreservation domain sits at the intersection of scientific innovation, operational rigor, and supply chain complexity. Advances in preservation chemistries and storage technologies are creating new opportunities to expand clinical programs and enable advanced therapies, while regulatory and commercial pressures are reshaping procurement and validation priorities. The combined effect is a shift toward integrated solutions that emphasize interoperability, data continuity, and resilient sourcing.

Organizations that proactively recalibrate procurement strategies, invest in digital monitoring, and align cross-functional stakeholders will be best positioned to realize the clinical and operational benefits of modern preservation techniques. Conversely, those that defer strategic upgrades risk increased wastage, constrained clinical capacity, and difficulties meeting regulatory expectations. Near-term priorities should therefore focus on supplier diversification, targeted capital allocation for interoperability, and institutionalizing training and validation practices.

Overall, a pragmatic, systems-oriented approach that balances technology adoption with rigorous quality governance will enable healthcare providers, research organizations, and commercial developers to convert preservation science into dependable operational capability. Stakeholders should treat the insights provided here as a foundation for targeted pilots, procurement decisions, and policy engagement that together will shape the reliability and scalability of biopreservation services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of automated cryopreservation systems to improve reproducibility and throughput in cell therapy manufacturing
  • 5.2. Development of novel ice recrystallization inhibitors for enhanced viability of preserved biologics during long-term storage
  • 5.3. Adoption of vitrification protocols in assisted reproductive technology to boost embryo and oocyte survival rates
  • 5.4. Integration of sustainable cryogen-free preservation technologies to reduce costs and environmental impact in biobanking
  • 5.5. Advances in lyophilization techniques for temperature-sensitive vaccines to extend shelf life without cold chain dependency
  • 5.6. Regulatory harmonization efforts to standardize quality control criteria for global biopreservation workflows and materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopreservation Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Cryoprotectants
      • 8.1.1.1. DMSO
      • 8.1.1.2. Glycerol
    • 8.1.2. Media
    • 8.1.3. Vials & Tubes
  • 8.2. Equipment
    • 8.2.1. Cryogenic Freezers
    • 8.2.2. Monitoring Systems
    • 8.2.3. Storage Systems

9. Biopreservation Market, by Technology

  • 9.1. Cryopreservation
  • 9.2. Hypothermic Storage
  • 9.3. Lyophilization
  • 9.4. Vitrification

10. Biopreservation Market, by Sample Type

  • 10.1. Biological Fluids
  • 10.2. Blood Components
  • 10.3. Cells
  • 10.4. Organs
  • 10.5. Tissues

11. Biopreservation Market, by Application

  • 11.1. Assisted Reproductive Technology
  • 11.2. Blood Preservation
  • 11.3. Cell Therapy
  • 11.4. Organ Preservation
  • 11.5. Tissue Engineering

12. Biopreservation Market, by End User

  • 12.1. Blood Banks
  • 12.2. Fertility Clinics
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical & Biotech Companies
  • 12.5. Research Institutes

13. Biopreservation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biopreservation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biopreservation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. Merck KGaA
    • 16.3.4. BioLife Solutions, Inc.
    • 16.3.5. Azenta, Inc.
    • 16.3.6. Cryoport, Inc.
    • 16.3.7. Avantor, Inc.
    • 16.3.8. Brooks Automation, Inc.
    • 16.3.9. Lonza Group AG
    • 16.3.10. Sartorius AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPRESERVATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOPRESERVATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOPRESERVATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOPRESERVATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPRESERVATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPRESERVATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPRESERVATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. GLOBAL BIOPRE